Artificial Intelligence

The 2024 Nobel Prize in Chemistry was awarded on Wednesday October 9, 2024, to three scientists for discoveries that show the potential of advanced technologies, including artificial intelligence, to predict the shape of proteins, and invent new ones.

AI-powered tools are transforming the healthcare sector and have already entered mainstream medical practice, to become a reality in many medical fields and specialties. Yet, as with any innovation, there are clear benefits, but also uncertainties and risks.

From the identification of target patients using unstructured data from medical records to the generation of personalized promotional and medical texts, all the way to interactive digital sales agents and self-managed customer support, generative AI will lead to revolutionary innovations in the pharmaceutical sector.

As generative AI becomes more widely deployed and adopted, it is set to fundamentally transform the way we do business in the future – assuming that workforce reconversion, and the inherent risks of this technology, can be mastered and controlled from the outset; the result will have a major impact on socio-economic progress.

The development and adoption of AI is profoundly transforming the future of work – not just job quality, but also how work is organized, the nature of the tasks we perform and therefore the skills that we’ll need.

From drug discovery to greater accuracy in early disease detection, diagnosis, and personalized treatment, AI could be the next game-changer in healthcare.